Evolent Health Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.8% | +15.0% | +1.2% | -4.0% | +4.0% | -25.2% | -8.1% | +7.9% | -2.3% | +5.9% | +31.5% | – | |
| – | +17.5% | +17.9% | +0.9% | +0.1% | +5.6% | -33.2% | -3.6% | +9.9% | +3.2% | +4.3% | +31.6% | – | |
| – | -18.3% | +2.4% | +2.6% | -24.5% | -6.2% | +35.3% | -24.9% | -1.4% | -31.2% | +18.6% | +30.6% | – | |
| – | +0.0% | -4.5% | +6.3% | – | – | – | – | – | – | – | – | – | |
| – | +123.0% | -56.1% | -12.5% | -3.1% | +18.0% | -0.9% | -4.1% | +3.2% | -6.4% | +0.2% | -5.5% | – | |
| – | -13.6% | -4.4% | -15.7% | -2.1% | -2.7% | +10.4% | -28.8% | +1.5% | -17.7% | +16.5% | +25.5% | – | |
| – | – | – | – | -308.9% | – | – | – | -76.7% | -1,565.0% | – | – | – | |
| – | -16.3% | -51.0% | 0.0% | +0.3% | +11.8% | +54.5% | +11.7% | +42.0% | +15.4% | -11.3% | -0.1% | – | |
| – | – | – | – | -1,849.3% | – | – | – | – | – | – | – | – | |
| – | – | – | -142.1% | – | – | – | -156.1% | – | -285.1% | – | +198.4% | – | |
| – | – | – | – | -1,549.7% | – | – | – | – | – | – | – | – | |
| – | -133.7% | – | +93.5% | -67.1% | +11.1% | -316.0% | – | +52.3% | -1,673.2% | – | -6.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.